
Validea's guru fundamental report indicates that NIKE INC (NKE) receives a 77% rating based on their P/B Growth Investor model, which is based on the strategy of Partha Mohanram and focuses on low book-to-market stocks with sustained future growth characteristics. The model positively assesses NIKE's book/market ratio, return on assets, cash flow from operations to assets, return on assets variance, sales variance, and advertising to assets, but it fails the criteria for capital expenditures to assets and research and development to assets. Mohanram's research identifies criteria to distinguish successful growth stocks from those that falter, challenging traditional views on growth investing.
NIKE INC (NKE) has received a 77% rating from Validea's P/B Growth Investor model, based on Partha Mohanram's strategy which targets low book-to-market stocks with indicators of sustained future growth. This score is approaching the 80% level that typically signals model interest, though it remains below the 90% threshold for strong interest. NKE passed several fundamental tests within this model, including book/market ratio, return on assets, cash flow from operations to assets, the ratio of cash flow from operations to assets versus return on assets, return on assets variance, sales variance, and advertising to assets. However, the company did not meet the model's criteria for capital expenditures to assets and research and development to assets. This mixed assessment suggests that while NKE exhibits multiple positive growth characteristics, its current levels of investment in capital assets and R&D, relative to its asset base, are flagged as potential weaknesses by this specific growth-oriented strategy. The overall sentiment surrounding this report is moderately positive, with a general sentiment score of 0.3 and a specific sentiment score for NKE of 0.5.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
Positive
Sentiment Score
0.30
Ticker Sentiment